Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.

Watson AM, Li J, Schumacher C, de Gasparo M, Feng B, Thomas MC, Allen TJ, Cooper ME, Jandeleit-Dahm KA.

Diabetologia. 2010 Jan;53(1):192-203. doi: 10.1007/s00125-009-1540-3. Epub 2009 Oct 28.

PMID:
19862499
2.

Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.

Gagliardini E, Corna D, Zoja C, Sangalli F, Carrara F, Rossi M, Conti S, Rottoli D, Longaretti L, Remuzzi A, Remuzzi G, Benigni A.

Am J Physiol Renal Physiol. 2009 Nov;297(5):F1448-56. doi: 10.1152/ajprenal.00340.2009. Epub 2009 Aug 12.

3.

The mesangial cell revisited: no cell is an island.

Schlöndorff D, Banas B.

J Am Soc Nephrol. 2009 Jun;20(6):1179-87. doi: 10.1681/ASN.2008050549. Epub 2009 May 21. Review.

4.

Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kappaB and AP-1.

Sutcliffe AM, Clarke DL, Bradbury DA, Corbett LM, Patel JA, Knox AJ.

Br J Pharmacol. 2009 Jun;157(3):436-50. doi: 10.1111/j.1476-5381.2009.00143.x. Epub 2009 Apr 9.

5.

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT.

Clin Chem. 2009 Apr;55(4):611-22. doi: 10.1373/clinchem.2008.112797. Epub 2009 Feb 26.

6.

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Huang da W, Sherman BT, Lempicki RA.

Nat Protoc. 2009;4(1):44-57. doi: 10.1038/nprot.2008.211.

7.

The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007.

Fioretto P, Caramori ML, Mauer M.

Diabetologia. 2008 Aug;51(8):1347-55. doi: 10.1007/s00125-008-1051-7. Epub 2008 Jun 5.

PMID:
18528679
8.

Effects of endothelin-1 on fibroblasts from type 2 diabetic patients: Possible role in wound healing and tissue repair.

Solini A, Santini E, Madec S, Cuccato S, Ferrannini E.

Growth Factors. 2007 Dec;25(6):392-9. doi: 10.1080/08977190801892341.

PMID:
18365870
9.

Oleate induces a myofibroblast-like phenotype in mesangial cells.

Mishra R, Simonson MS.

Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):541-7. Epub 2007 Dec 20.

10.

Phenotypic transitions and fibrosis in diabetic nephropathy.

Simonson MS.

Kidney Int. 2007 May;71(9):846-54. Epub 2007 Mar 7. Review.

11.

Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.

Rask-Madsen C, King GL.

Nat Clin Pract Endocrinol Metab. 2007 Jan;3(1):46-56. Review.

PMID:
17179929
12.

Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism.

Sasser JM, Sullivan JC, Hobbs JL, Yamamoto T, Pollock DM, Carmines PK, Pollock JS.

J Am Soc Nephrol. 2007 Jan;18(1):143-54. Epub 2006 Dec 13.

13.

Role of endothelin in fibrosis and anti-fibrotic potential of bosentan.

Clozel M, Salloukh H.

Ann Med. 2005;37(1):2-12. Review.

PMID:
15902842
14.

Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction.

Amiri F, Virdis A, Neves MF, Iglarz M, Seidah NG, Touyz RM, Reudelhuber TL, Schiffrin EL.

Circulation. 2004 Oct 12;110(15):2233-40. Epub 2004 Oct 4.

15.

Robustness of cellular functions.

Stelling J, Sauer U, Szallasi Z, Doyle FJ 3rd, Doyle J.

Cell. 2004 Sep 17;118(6):675-85. Review.

16.
17.

Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.

Shi-Wen X, Chen Y, Denton CP, Eastwood M, Renzoni EA, Bou-Gharios G, Pearson JD, Dashwood M, du Bois RM, Black CM, Leask A, Abraham DJ.

Mol Biol Cell. 2004 Jun;15(6):2707-19. Epub 2004 Mar 26.

18.

Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice.

Yang LL, Gros R, Kabir MG, Sadi A, Gotlieb AI, Husain M, Stewart DJ.

Circulation. 2004 Jan 20;109(2):255-61. Epub 2004 Jan 12.

19.

Physiology and pathology of endothelin-1 in renal mesangium.

Sorokin A, Kohan DE.

Am J Physiol Renal Physiol. 2003 Oct;285(4):F579-89. Review.

20.

Gene expression profile of endothelin-1-induced growth in glomerular mesangial cells.

Mishra R, Leahy P, Simonson MS.

Am J Physiol Cell Physiol. 2003 Nov;285(5):C1109-15. Epub 2003 Jul 9.

Supplemental Content

Support Center